What's Hot
View all perspectives
Janet Pope Janetbirdope
4 years ago
Tell me what do you focus more on in virtual learning? I will try to vary my backgrounds as a virtual home yours! @RheumNow @CRASCRRheum #ACR20
sheila RHEUMarampa
4 years ago
Nintedanib for RA-ILD? In the INBUILD Trial, pts on Nintedanib did better than PBO, efficacy similar among autoimmune ILDs including RA. @RheumNow #ACR20 @joanbathon https://t.co/I4AJlemIhD
Eric Dein ejdein1
4 years ago
Dr Hansen at 3S008 on "Bone for the Holidays": individualize the decision for drug holidays - here are the key questions: #acr20 @Rheumnow https://t.co/lMHtYW4OzE
Dr. Antoni Chan synovialjoints
4 years ago
Which Axial SpA outcome score do you use in clinic as a target to achieve? @RheumNow #ACR20
Dr. Rachel Tate uptoTate
4 years ago
In SpA-paz cohort 80% of axSpA pts achieved R or LDA at one visit, but only 40% maintained this level of disease control. #ABS0893 #ACR20 @RheumNow https://t.co/3MKBKOoNSw https://t.co/pTMJhtfKbU
k dao KDAO2011
4 years ago
OBRI Canadian registry showed real world retention data for Tofa and TNFi are both similar, but RA pts on TNFi w/o MTX d/c drug more compared to those who stay on MTX (does not matter with Tofa if they are on MTX)
Abstr#808 #ACR20 @rheumnow
https://t.co/TDmV0EJTp8
sheila RHEUMarampa
4 years ago
SEAM-RA: SDAI remission greater in pts on ETN alone vs. MTX alone; ⬆ pts in remission w/ combined tx vs. MTX alone. These may guide tx decisions re withdrawal in well-controlled RA @Rheumnow #ACR20 https://t.co/33GhuMuL3I
Dr. Antoni Chan synovialjoints
4 years ago
Wonderful Philip Hench Memorial Lecture from Prof Gerd Bursmester on the development of biologics in rheumatology from infections, the magic bullet, serendipity, perseverance, research to the present day @RheumNow #ACR20 #3S007 https://t.co/9H1AmZLTpJ
Janet Pope Janetbirdope
4 years ago
ACPA+ RA should likely NOT taper bDMARDs as less Bio survival if ACPA+ &/or monoRx. Should EULAR guidelines be changed? What about retention with JAKis? #ACR20 @RheumNow @CRASCRRheum abstr804 https://t.co/vjzIIgVJ0s
sheila RHEUMarampa
4 years ago
For patients with #rheumatic disease, what test do you request in the work-up for Latent TB infection? @RheumNow #ACR20
Robert B Chao, MD doctorRBC
4 years ago
Dr. Aggarwal Abs#0955 showed efficacy of IVIG in tx of Dermatomyositis.
How/when do you use IVIG for tx of DM?
@RheumNow #ACR20
Bella Mehta bella_mehta
4 years ago
Great talk by @lovetolearn27 Prosthetic joint infection doubles the risk of venous thromboembolism after revision of knee replacement. 15 yr data New York state -25K revisions! @RheumNow #ACR20 ABS#0960 https://t.co/4PHHSEstKs
David Liew drdavidliew
4 years ago
Never forget how far we have come in rheumatology therapeutics, in a very short period of time.
Some of the original slides that Tiny Maini and Marc Feldmann used. @r_burmester giving the Phillip Hench Lecture #ACR20 @RheumNow https://t.co/YI32BX2iw8
Robert B Chao, MD doctorRBC
4 years ago
Efficacy of IVIG in Dermatomyositis Treatment
1st Placebo controlled RCT
1️⃣79% responder by total improvement score vs. 44%
2️⃣Efficacy sustained thru wk 40
3️⃣6% serious AE - thromboembolic event
@RheumNow #ACR20 Abs#0955 #ACRbest https://t.co/715h1UkZ9X
Poster Hall